Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

This study is currently recruiting participants.
Verified December 2013 by Children's Hospital Boston
Sponsor:
Collaborators:
Children's Hospital Medical Center, Cincinnati
University of California, Los Angeles
Information provided by (Responsible Party):
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT01129544
First received: May 21, 2010
Last updated: December 12, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2030
  Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)